Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19
Monique G.P. van der Wijst(University Medical Center Groningen), Chun Ye(Universidad Católica de Santa Fe), Sabrina A Mann(University of California, San Francisco), Alyssa Ward(University of California, San Francisco), Raymund Bueno(University of California, San Francisco), David J. Erle(University of California, San Francisco), Paul Bastard(Inserm), Richard K. Perez(Stanford University), Tianna Grant(University of California, San Francisco), Carolyn M. Hendrickson(University of California, San Francisco), Matthew F. Krummel(University of California, San Francisco), Michail S. Lionakis(National Institute of Allergy and Infectious Diseases), Arjun A. Rao(University of California, San Francisco), Carina Marquez(University of California, San Francisco), Adrian Gervais(Inserm), Yichen Si(Broad Institute), Anton Ogorodnikov(University of California, San Francisco), Kathleen Kelly(Vitalant), John R. Greenland(University of California, San Francisco), Joseph L. DeRisi(University of California, San Francisco), Qian Zhang(Cixian People's Hospital), Jean‐Laurent Casanova(Howard Hughes Medical Institute), George C. Hartoularos(Innovative Genomics Institute), Yun S. Song(University of California, Berkeley), Philip J. Norris(University of California, San Francisco), Kara L. Lynch(University of California, San Francisco), Bryan Greenhouse(University of California, San Francisco), Cassandra Yun(University of California, San Francisco), Carolyn S. Calfee(University of California, San Francisco), Gabriel Chamie(University of California, San Francisco), Prescott G. Woodruff(University of California, San Francisco), Diane V. Havlir(University of California, San Francisco), Sara E. Vazquez(Massachusetts General Hospital), Larry J. Dumont(Dartmouth College), Alexis J. Combes(University of California, San Francisco), Alexander Whatley(University of California, Berkeley), Kirsten N. Kangelaris(San Francisco General Hospital), Gabriela K. Fragiadakis(Stanford University), Ashley Byrne(Chan Zuckerberg Initiative (United States)), Mark S. Anderson(University of California, San Francisco), Yang Sun(Kunming Medical University), Peng Zhang(Zhejiang Hospital), Tom Le Voyer(Inserm), David Lee(University of California, San Francisco), Charles Langelier(University of California, San Francisco)
Cited by 237
Related Papers
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
|Science|2000|2.6k
Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
|Science|2003|2.6k